Dr Deborah O’Neil is the CEO of Novabiotics, a leading clinical-stage biotechnology company. She talks to me about antibiotic resistance and the future of pharma with so-called ‘personalised medicines’.
There’s a significant shortage of people working in STEM, costing businesses £1.5 billion a year. Katherine Andrews, the Project Manager of ‘That’s RAD! Science’ is trying to change that by bringing STEM careers to life through educational picture books.
Joining me today is Rob Mather, the CEO of the Against Malaria Foundation. The foundation funds anti-malaria nets, specifically long-lasting insecticidal nets, LLINs.
Access to healthcare can be extremely limited, with the nearest health facility located hours away. Transaid is using bicycle ambulances to transport mothers and children.
What makes a public health animation effective and, as the NHS introduces an online quiz to determine heart age, will such quizzes have a greater role in public health?
Vaccines against malaria, HIV and Tuberculosis ‘unlikely’ unless funding triples, an investigational drug developed by Portland State University to go through clinical trials and 10,000 genetically modified mosquitoes are due to be set free in Africa.